Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

638 trials

NCT07649304
Recruiting
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Phase 1 · US · 1 site
Registry update: 5 Nov 2026
Fresh (updated this month)
NCT07875413
Not yet recruiting
Prizloncabtagene Autoleucel (Prizlon-cel) for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Post FDA Approved CAR T-cell Therapy
Phase 2 · US · 2 sites
Registry update: 15 Oct 2026
Fresh (updated this month)
NCT07883941
Not yet recruiting
Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid Neoplasms: First-in-human Administration, COLIBRI.
Phase 1 · - · no sites listed
Registry update: 20 Oct 2026
Fresh (updated this month)
NCT06902012
Recruiting
Safety and Efficacy of Early Second Infusion of Axi-cel Based on ctDNA for R/R Large B - Cell Lymphoma
Phase 1/2 · CN · 1 site
Registry update: 30 Mar 2025
Stale (updated 19 months ago)
NCT07906080
Not yet recruiting
Study to Evaluate the Feasibility and Safety of Autologous Cytokine-Induced Killer Cells (CIK_D332) in Combination With Tafasitamab and Lenalidomide in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Phase 1 · IT · 2 sites
Registry update: 3 Nov 2026
Fresh (updated this month)
NCT07729397
Not yet recruiting
Autologous IC-Nine, CD30 CAR, and Constitutive IL7R Expressing EBVST for CD30 Lymphoma (ANCILE-30)
Phase 1 · US · 1 site
Registry update: 27 Jul 2026
Fresh (updated 3 months ago)
NCT07749976
Not yet recruiting
GRACE: A Phase 1/2a Study of VTRU200 in Relapsed/Refractory AML, High-risk MDS, DLBCL Post CART Failure and Advanced Solid Tumors
Phase 1/2 · - · no sites listed
Registry update: 6 Aug 2026
Fresh (updated 3 months ago)
NCT07638982
Not yet recruiting
Axatilimab + CAR-T for High-Risk Lymphoma
Phase 1 · US · 1 site
Registry update: 16 Oct 2026
Fresh (updated this month)
NCT07164469
Not yet recruiting
Phase 2 Trial of CD70.CAR NK Cells for Patients With Primary Refractory or Early Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma
Phase 2 · US · 1 site
Registry update: 15 Jul 2026
Fresh (updated 3 months ago)
NCT07917754
Not yet recruiting
A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010)
Phase 2/3 · - · no sites listed
Registry update: 5 Nov 2026
Fresh (updated this month)
NCT07517705
Not yet recruiting
MRD-Adapted Low-Dose Radiation Therapy During Frontline Chemoimmunotherapy for Diffuse Large B-Cell Lymphoma
Phase 2 · US · 1 site
Registry update: 6 Nov 2026
Fresh (updated this month)
NCT07887646
Not yet recruiting
A Study Investigating the Safety and How the Trispecific T-Cell Engaging Antibody BG-T0920 Works in Adults With Diffuse Large B-cell Lymphoma (DLBCL) and Other Aggressive B-Cell Malignancies
Phase 1 · - · no sites listed
Registry update: 21 Oct 2026
Fresh (updated this month)
NCT07714421
Not yet recruiting
Epcoritamab and Pola-R-mini-CHP for the Treatment of Diffuse Large B Cell Lymphoma in Elderly or Unfit Patients
Phase 1 · US · 1 site
Registry update: 20 Jul 2026
Fresh (updated 3 months ago)
NCT07887750
Not yet recruiting
REGN9220 in Combination With Odronextamab in Adult Participants With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin Lymphomas (BCNHLs)
Phase 1/2 · - · no sites listed
Registry update: 21 Oct 2026
Fresh (updated this month)
NCT07654426
Not yet recruiting
The CARDIOPROTECT Trial
Phase 2 · US · 1 site
Registry update: 6 Nov 2026
Fresh (updated this month)
NCT07676877
Recruiting
Lymphodepletion With Low Dose Total Body Irradiation Before Standard of Care Tisagenlecleucel for the Treatment of Relapsed and Recurrent Large B-cell Lymphoma
Phase 1 · US · 1 site
Registry update: 9 Oct 2026
Fresh (updated this month)
NCT07634289
Not yet recruiting
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
Phase 2 · AU · 5 sites
Registry update: 8 Jun 2026
Fresh (updated 4 months ago)
NCT07814001
Not yet recruiting
Epcoritamab Plus Lenalidomide in Relapsed/Refractory Large B-cell Lymphoma After Second-Line CAR T-cell Therapy
Phase 2 · FR · 15 sites
Registry update: 10 Sept 2026
Fresh (updated 1 month ago)
NCT07881211
Not yet recruiting
A Study Investigating the Safety and How the Trispecific T-Cell Engaging Antibody BG-T0050 Works in Adults With Diffuse Large B-cell Lymphoma (DLBCL) and Other Aggressive B-Cell Malignancies
Phase 1 · - · no sites listed
Registry update: 19 Oct 2026
Fresh (updated this month)
NCT07882576
Not yet recruiting
A Study to Evaluate Treatment Patterns and Investigate Adult Patients With B-cell Lymphoma
Not applicable · BR · 5 sites
Registry update: 20 Oct 2026
Fresh (updated this month)

Ordered by registry start date. Freshness and sponsorship never change the order.